Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Suppressing certain hormones might help prevent prostate cancer.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Some birth control pills have a higher risk of blood clots than others.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.